BRPI0811787A2 - "célula aviária imortalizada, uso de uma célula imortalizada e processo para imortalizar uma célula aviária" - Google Patents

"célula aviária imortalizada, uso de uma célula imortalizada e processo para imortalizar uma célula aviária"

Info

Publication number
BRPI0811787A2
BRPI0811787A2 BRPI0811787-0A2A BRPI0811787A BRPI0811787A2 BR PI0811787 A2 BRPI0811787 A2 BR PI0811787A2 BR PI0811787 A BRPI0811787 A BR PI0811787A BR PI0811787 A2 BRPI0811787 A2 BR PI0811787A2
Authority
BR
Brazil
Prior art keywords
cell
immortalized
avian
immortalize
avian cell
Prior art date
Application number
BRPI0811787-0A2A
Other languages
English (en)
Inventor
Philippe Erbs
Marina Kapfer
Nathalie Silvestre
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39767102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0811787(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of BRPI0811787A2 publication Critical patent/BRPI0811787A2/pt
Publication of BRPI0811787B1 publication Critical patent/BRPI0811787B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151Methods of production or purification of viral material
    • C12N2710/24152Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/80Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0811787A 2007-07-03 2008-07-02 usos de uma célula imortalizada e processo para imortalizar uma célula aviária BRPI0811787B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07360030 2007-07-03
PCT/EP2008/058472 WO2009004016A1 (en) 2007-07-03 2008-07-02 Immortalized avian cell lines

Publications (2)

Publication Number Publication Date
BRPI0811787A2 true BRPI0811787A2 (pt) 2014-12-30
BRPI0811787B1 BRPI0811787B1 (pt) 2018-10-09

Family

ID=39767102

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811787A BRPI0811787B1 (pt) 2007-07-03 2008-07-02 usos de uma célula imortalizada e processo para imortalizar uma célula aviária

Country Status (15)

Country Link
US (2) US8361788B2 (pt)
EP (1) EP2176398B1 (pt)
JP (1) JP5421250B2 (pt)
KR (1) KR101528379B1 (pt)
CN (1) CN101688182A (pt)
AU (1) AU2008270317B2 (pt)
BR (1) BRPI0811787B1 (pt)
CA (1) CA2691868C (pt)
CR (1) CR11221A (pt)
ES (1) ES2618490T3 (pt)
IL (1) IL203029A (pt)
RU (1) RU2475536C2 (pt)
TW (1) TWI614342B (pt)
WO (1) WO2009004016A1 (pt)
ZA (1) ZA201000251B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357531B2 (en) 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
EP2429580A1 (en) * 2009-05-12 2012-03-21 Transgene SA Method for orthopoxvirus production and purification
US20120309056A1 (en) 2010-02-04 2012-12-06 Leon Arnaud Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
FR2956409A1 (fr) 2010-02-15 2011-08-19 Univ Claude Bernard Lyon Procedes pour optimiser la production virale par l'inactivation ou l'inhibition du gene hipk2 et cellules modifiees pour la production virale
FR2967072B1 (fr) 2010-11-05 2013-03-29 Univ Dundee Procede pour ameliorer la production de virus et semences vaccinales influenza
WO2012095514A1 (en) 2011-01-14 2012-07-19 Vivalis Recombinant protein production system
WO2013000982A1 (en) 2011-06-27 2013-01-03 Vivalis Method for screening cells
TWI575070B (zh) 2011-07-12 2017-03-21 傳斯堅公司 Hbv聚合酶突變體
WO2013045668A2 (en) 2011-09-29 2013-04-04 Transgene Sa Immunotherapy composition and regimen for treating hepatitis c virus infection
WO2013045658A1 (en) 2011-09-29 2013-04-04 Transgene Sa Immunotherapy composition and regimen for treating hepatitis c virus infection
JP6333814B2 (ja) 2012-07-10 2018-05-30 トランジェーヌ、ソシエテ、アノニムTransgene S.A. マイコバクテリア抗原ワクチン
WO2014009433A1 (en) 2012-07-10 2014-01-16 Transgene Sa Mycobacterium resuscitation promoting factor for use as adjuvant
CN104726409B (zh) * 2013-12-19 2017-12-29 普莱柯生物工程股份有限公司 一种永生化的鸭胚肝细胞系的制备方法和应用
EP3092000A1 (en) 2014-01-09 2016-11-16 Transgene SA Fusion of heterooligomeric mycobacterial antigens
AU2015357225B2 (en) 2014-12-01 2020-04-09 Transgene Sa Stable liquid vaccinia virus formulations
MX2017007196A (es) * 2014-12-04 2017-08-28 Intervet Int Bv Fibroblastos de embrion de pollo inmortalizados.
US20190134190A1 (en) 2016-05-04 2019-05-09 Transgene Sa Combination therapy with cpg tlr9 ligand
US20190328869A1 (en) 2016-10-10 2019-10-31 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
WO2018210804A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
JP7406377B2 (ja) 2017-05-15 2023-12-27 ヤンセン ファッシンズ アンド プリベンション ベーフェー 安定なウイルス含有組成物
IL271558B2 (en) 2017-06-21 2024-01-01 Transgene A vaccine tailored to the individual
US20210187100A1 (en) 2018-09-06 2021-06-24 Bavarian Nordic A/S Storage Improved Poxvirus Compositions
CN113474449A (zh) 2018-11-23 2021-10-01 瓦尔尼瓦公司 包括禽类干细胞的食物产品
FR3089789B1 (fr) 2018-12-14 2022-05-27 Univ Claude Bernard Lyon Production de vaccins viraux sur une lignee cellulaire aviaire
EP3842065A1 (en) 2019-12-23 2021-06-30 Transgene Process for designing a recombinant poxvirus for a therapeutic vaccine
BR112022017438A2 (pt) 2020-03-12 2022-10-18 Bavarian Nordic As Composições que melhoram a estabilidade do poxvírus
US20230256057A1 (en) 2020-07-13 2023-08-17 Transgene Treatment of immune depression
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749021B1 (fr) 1996-05-23 2001-10-26 Agronomique Inst Nat Rech Lignees de cellules aviaires immortalisees
US5672485A (en) 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
FR2777570A1 (fr) 1998-04-17 1999-10-22 Transgene Sa Mutant ayant une activite phosphoribosyl transferase
EP1103610A1 (en) * 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
CA2532783C (en) 2003-07-21 2013-09-17 Transgene S.A. Polypeptide having an improved cytosine deaminase activity
DE602004027141D1 (de) 2003-07-22 2010-06-24 Vivalis Produktion von poxviren mit adhärenten oder nicht adhärenten vogelzellinien
EP1528101A1 (en) * 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production

Also Published As

Publication number Publication date
KR101528379B1 (ko) 2015-06-16
WO2009004016A1 (en) 2009-01-08
CA2691868A1 (en) 2009-01-08
RU2475536C2 (ru) 2013-02-20
US20130244246A1 (en) 2013-09-19
EP2176398B1 (en) 2016-12-28
US8361788B2 (en) 2013-01-29
TWI614342B (zh) 2018-02-11
AU2008270317A1 (en) 2009-01-08
AU2008270317B2 (en) 2013-12-05
CN101688182A (zh) 2010-03-31
US8809056B2 (en) 2014-08-19
ES2618490T3 (es) 2017-06-21
RU2010102668A (ru) 2011-08-10
CR11221A (es) 2010-03-22
IL203029A (en) 2013-07-31
US20100197010A1 (en) 2010-08-05
EP2176398A1 (en) 2010-04-21
BRPI0811787B1 (pt) 2018-10-09
CA2691868C (en) 2016-12-20
KR20100035650A (ko) 2010-04-05
JP2010531654A (ja) 2010-09-30
ZA201000251B (en) 2010-09-29
TW200911994A (en) 2009-03-16
JP5421250B2 (ja) 2014-02-19

Similar Documents

Publication Publication Date Title
BRPI0811787A2 (pt) "célula aviária imortalizada, uso de uma célula imortalizada e processo para imortalizar uma célula aviária"
BRPI0807612A2 (pt) Marcadores metabólicos de condições diabéticas e métodos de uso do mesmo
BRPI0814075A2 (pt) Processo para separar pelo menos um material hidrofóbico de uma mistura, e, uso de uma superfície sólida, hidrofóbica
BRPI0921320A2 (pt) composições de anticorpo estáveis e métodos para estabilizar os mesmos
BRPI0905663A2 (pt) "emulsão estável, processo de preparação da emulsão estável e uso emulsão"
BRPI0916630A2 (pt) composições para uso em construção e processo de aplicação das mesmas
BRPI0916884A2 (pt) composição imunogênica, processo para preparar uma composição imunogênica, uso de uma composição imunogênica, e, kit
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BR112012033538A2 (pt) linhagem celular imortalizada e método de replicação de um vírus
BR112013009483A2 (pt) "estrutura substancialmente desprovida de celulose para utilização em um artigo absorvente, artigo absorvente e método de fabricação de uma estrutura abosrvente"
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI1007867A2 (pt) anticorpos para troponina i e método s de uso para os mesmos
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
BRPI0905712A2 (pt) "conjunto de células de bateria e método para construção do conjunto de células de bateria"
BRPI0818959A2 (pt) "artigos e métodos para coleta de amostras ambientais"
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
BRPI0921399A2 (pt) composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante
BRPI0903495A2 (pt) microorganismos mutantes com capacidade de produzir putrescina e método para produção de putrescina utilizando os mesmos
BRPI0717695A2 (pt) "composição, uso de uma compsição e processo de preparação de uma composição"
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI0918487A2 (pt) processo para a preparação de uma composição de copolímero, composição, e, uso de uma composição de copolímero
BRPI1010540A2 (pt) "anticorpos especéficos para dkk-1 e seus usos"
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0813456A2 (pt) Composto, uso do mesmo, composição farmacêutica, e, métodos para tratar um mamífero sofrendo de um distúrbio e de uma doença
BRPI0807220B1 (pt) composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REFERENTE A RPI NO 2407 DE 21/02/2017.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C12N 5/071 (2010.01), C12N 15/85 (2006.01), C12N 7

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/10/2018, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.